Table 6. Donor and recipient characteristics in examined groups (standard and IBT).
| STANDARD | IBT | p | |
|---|---|---|---|
| Donor gender | 10F/13M | ||
| Donor age (years, mean ± SD) | 48 ± 12 | ||
| Donor last creatinine (mg/dL) | 1.13 ± 0.46 | ||
| Donor cause of death | 16 cerebrovascular accident, 7 other | ||
| CIT (hours, mean ± SD) | 28.6 ± 7.4 | 27.4 ± 7.5 | ns |
| WIT (minutes, mean ± SD) | 23.6 ± 8.1 | 0 | p < 0.0001 |
| Recipient gender | 10F/13M | 7F/16M | ns |
| Recipient age (years, mean ± SD) | 50 ± 13 | 52 ± 10 | ns |
| Primary kidney disease: | |||
| Chronic glomerulonephritis | 10 | 10 | |
| Hypertensive nephropathy | 4 | 6 | |
| Polycystic renal disease | 1 | 3 | |
| Chronic interstitial nephritis | 6 | 1 | |
| Other/unknown | 2 | 3 | |
| Time of dialysis before transplantation (months, mean ± SD) | 27.5 ± 19.8 | 28.0 ± 18.1 | ns |
| Dialysis method (HD/PD) | 19/4 | 20/3 | ns |
| HLA mismatches (mean ± SD) | 4.1 ± 1.1 | 3.9 ± 1.0 | ns |
| Max. PRA >20% | 4 | 2 | ns |
| Last PRA >20% | 2 | 0 | ns |
| Second transplant | 4 | 1 | ns |
| Immunosuppression | |||
| TAC/MPA/steroids | 16 | 13 | |
| CsA/MPA/steroids | 7 | 9 | |
| mTORI/TAC/steroids | 1 | ||
| Induction with anti-CD25 | 1 | 2 | |
*HD-hemodialysis, PD-peritoneal dialysis, PRA-panel reactive antibodies, TAC-tacrolimus, MPA- mycophenolate mofetil/sodium, CsA-cyclosporine A, mTORI- mTOR inhibitors.